Helicobacter pylori neutrophil activating protein as target for new drugs against H. pylori inflammation

World Journal of Gastroenterology

Volumn 17, Issue 21, 2011, Pages 2585-2591

  Choli Papadopoulou, Theodora ^a   Kottakis, Filippos ^a,b   Papadopoulos, Georgios ^c,d   Pendas, Stefanos ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b TUFTS MEDICAL CENTER   (United States)

^c UNIVERSITY OF THESSALY   (Greece)

^d UNIVERSITY OF PATRAS   (Greece)

Author keywords

Gastric cancer; Helicobacter pylori; Helicobacter pylori neutrophil activating protein; Peptic ulcer disease

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIOXIDANT; ARABINO GALACTAN PROTEIN; CHEMOKINE; CHIOS MASTIC GUM; CLARITHROMYCIN; DIMER; HELICOBACTER PYLORI NEUTROPHIL ACTIVATING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 23; METRONIDAZOLE; NATURAL PRODUCT; PLANT MEDICINAL PRODUCT; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; CARBOXY TERMINAL SEQUENCE; CELL ACTIVATION; CELL ADHESION; CHRONIC GASTRITIS; DIMERIZATION; DRUG TREATMENT FAILURE; ENDOTHELIUM CELL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; INFLAMMATION; LEUKOCYTE; MOLECULAR DYNAMICS; NEUTROPHIL; OXIDATIVE STRESS; PISTACIA LENTISCUS; PREVALENCE; PROTEIN SECRETION; RECURRENT DISEASE; STOMACH PAIN; TH1 CELL; TRADITIONAL MEDICINE;

EID: 79958024656     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i21.2585     Document Type: Article

References (51)

1. Yoshida N, Granger DN, Evans DJ Jr, Evans DG, Graham DY, Anderson DC, Wolf RE, Kvietys PR. Mechanisms involved in Helicobacter pylori-induced inflammation. Gastroenterology 1993; 105: 1431-1440
2. Kurose I, Granger DN, Evans DJ Jr, Evans DG, Graham DY, Miyasaka M, Anderson DC, Wolf RE, Cepinskas G, Kvietys PR. Helicobacter pylori-induced microvascular protein leakage in rats: role of neutrophils, mast cells, and platelets. Gastroenterology 1994; 107: 70-79
3. Evans DJ Jr, Evans DG, Lampert HC, Nakano H. Identification of four new prokaryotic bacterioferritins, from Helicobacter pylori, Anabaena variabilis, Bacillus subtilis and Treponema pallidum, by analysis of gene sequences. Gene 1995; 153: 123-127
4. Montemurro P, Barbuti G, Dundon WG, Del Giudice G, Rappuoli R, Colucci M, De Rinaldis P, Montecucco C, Semeraro N, Papini E. Helicobacter pylori neutrophil-activating protein stimulates tissue factor and plasminogen activator inhibitor-2 production by human blood mononuclear cells. J Infect Dis 2001; 183: 1055-1062
5. Satin B, Del Giudice G, Della Bianca V, Dusi S, Laudanna C, Tonello F, Kelleher D, Rappuoli R, Montecucco C, Rossi F. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med 2000; 191: 1467-1476
6. Montemurro P, Nishioka H, Dundon WG, de Bernard M, Del Giudice G, Rappuoli R, Montecucco C. The neutrophilactivating protein (HP-NAP) of Helicobacter pylori is a potent stimulant of mast cells. Eur J Immunol 2002; 32: 671-676
7. Teneberg S, Miller-Podraza H, Lampert HC, Evans DJ Jr, Evans DG, Danielsson D, Karlsson KA. Carbohydrate binding specificity of the neutrophil-activating protein of Helicobacter pylori. J Biol Chem 1997; 272: 19067-19071
8. Namavar F, Sparrius M, Veerman EC, Appelmelk BJ, Vandenbroucke-Grauls CM. Neutrophil-activating protein mediates adhesion of Helicobacter pylori to sulfated carbohydrates on high-molecular-weight salivary mucin. Infect Immun 1998; 66: 444-447
9. Montecucco C, de Bernard M. Molecular and cellular mechanisms of action of the vacuolating cytotoxin (VacA) and neutrophil-activating protein (HP-NAP) virulence factors of Helicobacter pylori. Microbes Infect 2003; 5: 715-721
10. Nishioka H, Baesso I, Semenzato G, Trentin L, Rappuoli R, Del Giudice G, Montecucco C. The neutrophil-activating protein of Helicobacter pylori (HP-NAP) activates the MAPK pathway in human neutrophils. Eur J Immunol 2003; 33: 840-849
11. Evans DJ Jr, Evans DG, Takemura T, Nakano H, Lampert HC, Graham DY, Granger DN, Kvietys PR. Characterization of a Helicobacter pylori neutrophil-activating protein. Infect Immun 1995; 63: 2213-2220
12. Tonello F, Dundon WG, Satin B, Molinari M, Tognon G, Grandi G, Del Giudice G, Rappuoli R, Montecucco C. The Helicobacter pylori neutrophil-activating protein is an ironbinding protein with dodecameric structure. Mol Microbiol 1999; 34: 238-246
13. Dundon WG, Polenghi A, Del Guidice G, Rappuoli R, Montecucco C. Neutrophil-activating protein (HP-NAP) versus ferritin (Pfr): comparison of synthesis in Helicobacter pylori. FEMS Microbiol Lett 2001; 199: 143-149
14. Zanotti G, Papinutto E, Dundon W, Battistutta R, Seveso M, Giudice G, Rappuoli R, Montecucco C. Structure of the neutrophil-activating protein from Helicobacter pylori. J Mol Biol 2002; 323: 125-130
15. Grant RA, Filman DJ, Finkel SE, Kolter R, Hogle JM. The crystal structure of Dps, a ferritin homolog that binds and protects DNA. Nat Struct Biol 1998; 5: 294-303
16. Wolf SG, Frenkiel D, Arad T, Finkel SE, Kolter R, Minsky A. DNA protection by stress-induced biocrystallization. Nature 1999; 400: 83-85
17. Buda F, Ensing B, Gribnau MC, Baerends EJ. O2 evolution in the Fenton reaction. Chemistry 2003; 9: 3436-3444
18. Bozzi M, Mignogna G, Stefanini S, Barra D, Longhi C, Valenti P, Chiancone E. A novel non-heme iron-binding ferritin related to the DNA-binding proteins of the Dps family in Listeria innocua. J Biol Chem 1997; 272: 3259-3265
19. Ceci P, Ilari A, Falvo E, Chiancone E. The Dps protein of Agrobacterium tumefaciens does not bind to DNA but protects it toward oxidative cleavage: x-ray crystal structure, iron binding, and hydroxyl-radical scavenging properties. J Biol Chem 2003; 278: 20319-20326
20. Hong Y, Wang G, Maier RJ. Helicobacter hepaticus Dps protein plays an important role in protecting DNA from oxidative damage. Free Radic Res 2006; 40: 597-605
21. Yamamoto Y, Poole LB, Hantgan RR, Kamio Y. An ironbinding protein, Dpr, from Streptococcus mutans prevents iron-dependent hydroxyl radical formation in vitro. J Bacteriol 2002; 184: 2931-2939
22. Zhao G, Ceci P, Ilari A, Giangiacomo L, Laue TM, Chiancone E, Chasteen ND. Iron and hydrogen peroxide detoxification properties of DNA-binding protein from starved cells. A ferritin-like DNA-binding protein of Escherichia coli. J Biol Chem 2002; 277: 27689-27696
23. Ishikawa T, Mizunoe Y, Kawabata S, Takade A, Harada M, Wai SN, Yoshida S. The iron-binding protein Dps confers hydrogen peroxide stress resistance to Campylobacter jejuni. J Bacteriol 2003; 185: 1010-1017
24. Olczak AA, Olson JW, Maier RJ. Oxidative-stress resistance mutants of Helicobacter pylori. J Bacteriol 2002; 184: 3186-3193
25. Cooksley C, Jenks PJ, Green A, Cockayne A, Logan RP, Hardie KR. NapA protects Helicobacter pylori from oxidative stress damage, and its production is influenced by the ferric uptake regulator. J Med Microbiol 2003; 52: 461-469
26. Kottakis F, Papadopoulos G, Pappa EV, Cordopatis P, Pentas S, Choli-Papadopoulou T. Helicobacter pylori neutrophil-activating protein activates neutrophils by its C-terminal region even without dodecamer formation, which is a prerequisite for DNA protection--novel approaches against Helicobacter pylori inflammation. FEBS J 2008; 275: 302-317
27. Polenghi A, Bossi F, Fischetti F, Durigutto P, Cabrelle A, Tamassia N, Cassatella MA, Montecucco C, Tedesco F, de Bernard M. The neutrophil-activating protein of Helicobacter pylori crosses endothelia to promote neutrophil adhesion in vivo. J Immunol 2007; 178: 1312-1320
28. Laurence JS, Blanpain C, De Leener A, Parmentier M, Li-Wang PJ. Importance of basic residues and quaternary structure in the function of MIP-1 beta: CCR5 binding and cell surface sugar interactions. Biochemistry 2001; 40: 4990-4999
29. Yang Y, Mayo KH, Daly TJ, Barry JK, La Rosa GJ. Subunit association and structural analysis of platelet basic protein and related proteins investigated by 1H NMR spectroscopy and circular dichroism. J Biol Chem 1994; 269: 20110-20118
30. Amedei A, Cappon A, Codolo G, Cabrelle A, Polenghi A, Benagiano M, Tasca E, Azzurri A, D'Elios MM, Del Prete G, de Bernard M. The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J Clin Invest 2006; 116: 1092-1101
31. Long M, Luo J, Li Y, Zeng FY, Li M. Detection and evaluation of antibodies against neutrophil-activating protein of Helicobacter pylori in patients with gastric cancer. World J Gastroenterol 2009; 15: 2381-2388
32. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745-2756
33. Malfertheiner P, Schultze V, Rosenkranz B, Kaufmann SH, Ulrichs T, Novicki D, Norelli F, Contorni M, Peppoloni S, Berti D, Tornese D, Ganju J, Palla E, Rappuoli R, Scharschmidt BF, Del Giudice G. Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study. Gastroenterology 2008; 135: 787-795
34. Kottakis F, Lamari F, Matragkou Ch, Zachariadis G, Karamanos N, Choli-Papadopoulou T. Arabino-galactan proteins from Pistacia lentiscus var. chia: isolation, characterization and biological function. Amino Acids 2008; 34: 413-420
35. Al-Habbal MJ, Al-Habbal Z, Huwez FU. A double-blind controlled clinical trial of mastic and placebo in the treatment of duodenal ulcer. Clin Exp Pharmacol Physiol 1984; 11: 541-544
36. Kottakis F, Kouzi-Koliakou K, Pendas S, Kountouras J, Choli-Papadopoulou T. Effects of mastic gum Pistacia lentiscus var. Chia on innate cellular immune effectors. Eur J Gastroenterol Hepatol 2009; 21: 143-149
37. Costa F, D'Elios MM. Management of Helicobacter pylori infection. Expert Rev Anti Infect Ther 2010; 8: 887-892
38. Koizumi W, Tanabe S, Nakatani K, Ishido K, Nishimura K, Azuma M, Ae T, Sasaki T, Higuchi K, Katada C, Nakayama N, Saigenji K. Quadruple therapy with ecabet sodium, omeprazole, amoxicillin and metronidazole is effective for eradication of Helicobacter pylori after failure of firstline therapy (KDOG0201 Study). J Clin Pharm Ther 2010; 35: 303-307
39. Agudo S, Pérez-Pérez G, Alarcón T, López-Brea M. High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in Madrid, Spain. J Clin Microbiol 2010; 48: 3703-3707
40. Ben Mansour K, Burucoa C, Zribi M, Masmoudi A, Karoui S, Kallel L, Chouaib S, Matri S, Fekih M, Zarrouk S, Labbene M, Boubaker J, Cheikh I, Hriz MB, Siala N, Ayadi A, Filali A, Mami NB, Najjar T, Maherzi A, Sfar MT, Fendri C. Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study. Ann Clin Microbiol Antimicrob 2010; 9: 22
41. Garcia GT, Aranda KR, Gonçalves ME, Cardoso SR, Iriya K, Silva NP, Scaletsky IC. High prevalence of clarithromycin resistance and cagA, vacA, iceA2, and babA2 genotypes of Helicobacter pylori in Brazilian children. J Clin Microbiol 2010; 48: 4266-4268
42. Leal YA, Gómez A, Madrazo-de la Garza A, Ramos I, Muñoz O, Torres J. A primary Helicobacter pylori infection does not protect against reinfection in children after eradication therapy. Rev Invest Clin 2008; 60: 470-477
43. Niv Y, Hazazi R, Waked A, Lederfein T, Achiel K. Helicobacter pylori recurrence and infection rate in Israeli adults. Dig Dis Sci 2008; 53: 1211-1214
44. Ryu KH, Yi SY, Na YJ, Baik SJ, Yoon SJ, Jung HS, Song HJ. Reinfection rate and endoscopic changes after successful eradication of Helicobacter pylori. World J Gastroenterol 2010; 16: 251-255
45. Silva FM, Navarro-Rodriguez T, Barbuti RC, Mattar R, Hashimoto CL, Eisig JN. Helicobacter pylori reinfection in Brazilian patients with peptic ulcer disease: a 5-year followup. Helicobacter 2010; 15: 46-52
46. Niv Y. H pylori recurrence after successful eradication. World J Gastroenterol 2008; 14: 1477-1478
47. Abdel-Latif MM, Windle HJ, Homasany BS, Sabra K, Kelleher D. Caffeic acid phenethyl ester modulates Helicobacter pylori-induced nuclear factor-kappa B and activator protein-1 expression in gastric epithelial cells. Br J Pharmacol 2005; 146: 1139-1147
48. Lee IO, Lee KH, Pyo JH, Kim JH, Choi YJ, Lee YC. Antiinflammatory effect of capsaicin in Helicobacter pyloriinfected gastric epithelial cells. Helicobacter 2007; 12: 510-517
49. Lee KM, Yeo M, Choue JS, Jin JH, Park SJ, Cheong JY, Lee KJ, Kim JH, Hahm KB. Protective mechanism of epigallocatechin-3-gallate against Helicobacter pylori-induced gastric epithelial cytotoxicity via the blockage of TLR-4 signaling. Helicobacter 2004; 9: 632-642
50. Toyoda T, Tsukamoto T, Takasu S, Shi L, Hirano N, Ban H, Kumagai T, Tatematsu M. Anti-inflammatory effects of caffeic acid phenethyl ester (CAPE), a nuclear factor-kappaB inhibitor, on Helicobacter pylori-induced gastritis in Mongolian gerbils. Int J Cancer 2009; 125: 1786-1795
51. Kottakis F, Befani C, Asiminas A, Kontou M, Koliakos G, Choli-Papadopoulou T. The C-terminal region of HPNAP activates neutrophils and promotes their adhesion to endothelial cells. Helicobacter 2009; 14: 177-179